Preoperative Changes in Hematological Markers and Predictors of Glioma Grade and Survival
Background: Preoperative hematological markers that indicate nutritional, coagulation, and inflammation statuses have prognostic value for gliomas. This study aimed to investigate hematological markers with regard to tumor grades, isocitrate dehydrogenase mutations (IDH), age, and sex in patients wi...
Main Authors: | Peng-Fei Wang, Zhe Meng, Hong-Wang Song, Kun Yao, Ze-Jun Duan, Chun-Jiang Yu, Shou-Wei Li, Chang-Xiang Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00886/full |
Similar Items
-
Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection
by: Lidia Gatto, et al.
Published: (2024-01-01) -
Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
by: Xiangyang Deng, et al.
Published: (2019-11-01) -
IDH1 Non-Canonical Mutations and Survival in Patients with Glioma
by: Enrico Franceschi, et al.
Published: (2021-02-01) -
Cognitive functioning in a cohort of high-grade glioma patients
by: Skufca Smrdel Andreja Cirila, et al.
Published: (2023-06-01) -
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas
by: Zenghui Qian, et al.
Published: (2018-06-01)